CBIZ (NYSE:CBZ - Get Free Report) is expected to post its Q1 2025 quarterly earnings results before the market opens on Thursday, April 24th. Analysts expect the company to announce earnings of $2.13 per share and revenue of $860.25 million for the quarter.
CBIZ Price Performance
CBIZ stock traded down $2.84 during trading hours on Monday, reaching $74.62. 348,497 shares of the stock were exchanged, compared to its average volume of 331,563. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.36. CBIZ has a twelve month low of $62.66 and a twelve month high of $90.13. The company has a market cap of $4.03 billion, a P/E ratio of 31.62 and a beta of 0.90. The stock has a 50 day moving average of $76.45 and a two-hundred day moving average of $77.85.
Insider Activity at CBIZ
In other CBIZ news, Director Benaree Pratt Wiley sold 6,526 shares of the company's stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $71.75, for a total value of $468,240.50. Following the completion of the transaction, the director now owns 41,759 shares of the company's stock, valued at $2,996,208.25. This represents a 13.52 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 4.95% of the stock is currently owned by insiders.
Analysts Set New Price Targets
Several research analysts have commented on CBZ shares. StockNews.com downgraded shares of CBIZ from a "hold" rating to a "sell" rating in a research report on Tuesday, February 25th. William Blair reissued an "outperform" rating on shares of CBIZ in a report on Thursday, February 27th.
View Our Latest Research Report on CBZ
About CBIZ
(
Get Free Report)
CBIZ, Inc provides financial, insurance, and advisory services in the United States and Canada. It operates through Financial Services, Benefits and Insurance Services, and National Practices segments. The Financial Services segment offers accounting and tax, financial advisory, valuation, risk and advisory, and government healthcare consulting services.
See Also
Before you consider CBIZ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CBIZ wasn't on the list.
While CBIZ currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
